Global X Management Co LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 459,074 shares of the medical equipment provider’s stock after selling 30,620 shares during the period. Intuitive Surgical makes up about 3.9% of Global X Management Co LLC’s investment portfolio, making the stock its 2nd largest holding. Global X Management Co LLC owned approximately 0.40% of Intuitive Surgical worth $219,658,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Adviser Investments LLC bought a new position in shares of Intuitive Surgical in the second quarter valued at $115,000. Signet Financial Management LLC acquired a new stake in Intuitive Surgical during the 2nd quarter valued at $115,000. Psagot Investment House Ltd. acquired a new stake in Intuitive Surgical during the 2nd quarter valued at $133,000. Kaizen Advisory LLC raised its stake in Intuitive Surgical by 156.0% during the 2nd quarter. Kaizen Advisory LLC now owns 279 shares of the medical equipment provider’s stock valued at $133,000 after purchasing an additional 170 shares during the period. Finally, Rockefeller Capital Management L.P. acquired a new stake in Intuitive Surgical during the 2nd quarter valued at $142,000. 84.76% of the stock is currently owned by institutional investors.

Several analysts have issued reports on ISRG shares. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $582.00 target price on the stock in a research note on Tuesday, July 24th. BidaskClub downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 31st. Cantor Fitzgerald reissued a “buy” rating and set a $620.00 target price (up from $510.00) on shares of Intuitive Surgical in a research note on Friday, July 20th. Morgan Stanley reissued an “overweight” rating and set a $575.00 target price (up from $535.00) on shares of Intuitive Surgical in a research note on Friday, July 20th. Finally, Goldman Sachs Group boosted their target price on shares of Intuitive Surgical from $540.00 to $630.00 and gave the company a “buy” rating in a research note on Friday, July 20th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. Intuitive Surgical currently has an average rating of “Buy” and an average target price of $520.08.

In other news, Director Michael A. Friedman sold 2,070 shares of the company’s stock in a transaction on Friday, September 7th. The shares were sold at an average price of $541.46, for a total value of $1,120,822.20. Following the transaction, the director now directly owns 5,964 shares of the company’s stock, valued at $3,229,267.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Lonnie M. Smith sold 56,000 shares of the company’s stock in a transaction on Tuesday, July 24th. The stock was sold at an average price of $523.37, for a total transaction of $29,308,720.00. Following the completion of the transaction, the director now directly owns 11,874 shares in the company, valued at $6,214,495.38. The disclosure for this sale can be found here. Insiders sold 109,463 shares of company stock worth $57,194,982 over the last ninety days. 2.20% of the stock is currently owned by company insiders.

NASDAQ ISRG opened at $558.65 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $337.80 and a 1-year high of $572.96. The firm has a market capitalization of $64.65 billion, a PE ratio of 77.70, a P/E/G ratio of 4.16 and a beta of 0.86.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 19th. The medical equipment provider reported $2.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.02 by $0.74. Intuitive Surgical had a net margin of 23.20% and a return on equity of 20.56%. The business had revenue of $909.30 million for the quarter, compared to the consensus estimate of $877.43 million. During the same period in the prior year, the business posted $5.95 earnings per share. Intuitive Surgical’s revenue for the quarter was up 19.8% compared to the same quarter last year. research analysts predict that Intuitive Surgical, Inc. will post 9.31 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Read More: Calculate Your Return on Investment (ROI)

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.